Full-Time

Staff Mechanical Engineer

Intuitive Surgical

Intuitive Surgical

10,001+ employees

Manufactures robotic surgical systems and services

No salary listed

Sunnyvale, CA, USA

In Person

Master's, PhD

Category
Mechanical Engineering
Required Skills
CAD
Mechatronics
SolidWorks
FEM/FEA

Get referred to Intuitive Surgical

See people who can refer or advise you

Requirements
  • Twelve (12) years of experience in mechanical product design, or eight (8) years with MS, five (5) with PhD
  • Extensive experience taking products from concept to production. Medical and/or regulated product experience highly preferred.
  • Familiarity with all phases of the product development lifecycle including design, implementation, debug, verification, validation, qualification, and transfer
  • Understanding of mechatronics, robotics, and servo-controlled systems strongly preferred. Experience developing software control algorithms a plus.
  • Proven ability to apply the basic laws of physics to understand and achieve quick and reliable solutions to engineering problems
  • Exceptional mechanical aptitude and visual thinking skills
  • Strong analytical and problem-solving skills such as finite element analysis, statistics, and experimental designs
  • Experience with and knowledge of a wide range of prototyping processes, both rapid and conventional with a variety of metallic and non-metallic materials.
  • Excellent written and verbal communication and presentation skills. Ability to present to a wide range of audiences, including senior executives.
  • Ability to interface with customers and potential business partners in a highly professional manner
  • Proven ability to work well in a team environment as well as “solo” projects. Experience managing partners and small projects.
  • Proficiency using CAD to create and document mechanical designs. SolidWorks preferred.
  • Proficient with electromechanical prototyping and test methods, including use of hand tools, machine shop equipment, 3D printers, soldering, and mechanical and electrical test equipment
Responsibilities
  • Work within cross-functional project teams to create, evaluate, and prove out new product architectures and refine them for hand off to new Product Development
  • Collaborate with subject matter experts to understand the clinical, usability, and other needs of users of da Vinci systems as they relate to surgical instruments and accessories. Assist with market research and surgeon discussions around concepts, approaches, and procedures.
  • Develop technical requirements for designs based on an understanding of customer needs, commercial objectives (e.g. cost of goods), regulatory requirements, and feasibility constraints
  • Perform conceptual design, detailed design, analytical modeling, prototyping, data analysis, and troubleshooting of novel instruments and accessories for the da Vinci robotic surgical system
  • Develop and perform early performance testing, with assistance from other functions as needed. Assist with evaluation of prototypes by supporting bench, ex-vivo, and in-vivo laboratory testing with clinical experts.
  • Develop and manage relationships with key partners
  • Provide written protocols, reports, and presentations related to design activities on an ongoing basis
  • Document product designs as needed to support successful transfer into the new product development organization
  • Technical leadership
  • Act as technical lead on product development projects
  • Mentor and train less experienced engineers in the art of product development and mechanical design
  • Review mechanical engineering designs of other Intuitive engineers in both a formal and informal capacity
  • Lead or assist other design engineers through brainstorming, detailed reviews, and collaborative problem-solving, resulting in compelling product architectures
  • Provide detailed input to project planning, including objectives, budgets, staffing, schedules, milestones, etc.
  • Make recommendations to senior management about the direction, activities, and staffing of ongoing projects, as well as recommendations and proposals for new product/project opportunities
  • Identify resource gaps and make recommendations to address issues and prioritize
  • Other Functions
  • Assess technologies from outside entities for potential licensing and adaptation to the da Vinci product line
  • Identify, test, and report on new materials, manufacturing processes, and technologies that could benefit existing products or enable new product designs
  • Document, prepare and review patent submissions
  • May supervise or direct the activities of others
Desired Qualifications
  • Experience and skills in design of high volume (e.g. injection molded, MIM) components, and design for manufacturability strongly preferred

Intuitive Surgical designs, manufactures, and sells robotic surgical systems and provides related services and accessories for minimally invasive surgery. The core product helps surgeons perform operations with enhanced precision by guiding robotic arms controlled from a console, allowing procedures to be done through small incisions. Instruments and consumables are used with the systems and are supported by service contracts, creating a recurring revenue stream. Compared to competitors, Intuitive has a large installed base and focuses specifically on robotic-assisted surgery, combining devices, disposable instruments, and ongoing services to support hospitals and surgical centers. Its goal is to improve patient outcomes by enabling safer, less invasive procedures while expanding the use and capabilities of robotic surgery for more procedures and providers.

Company Size

10,001+

Company Stage

IPO

Headquarters

Sunnyvale, California

Founded

1995

Get referred to Intuitive Surgical

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • Q2 2026 revenue rose 19% to $2.89 billion, beating estimates again.
  • Intuitive raised 2026 da Vinci procedure growth guidance to 13.5%-15.5%.
  • Asia-Pacific demand supports Penang operations starting 2028 and 1,200 jobs by 2032.

What critics are saying

  • FDA Class II recalls in 2026 hit da Vinci X, Xi, and SP components.
  • US da Vinci growth slowed to 12% in Q2 2026, signaling elective-procedure deferral.
  • Medtronic's Hugo and other robotic entrants erode Intuitive's pricing power by 2027.

What makes Intuitive Surgical unique

  • Da Vinci 5 deepens Intuitive Surgical's installed-base moat; Q2 2026 placements hit 468.
  • Recurring instruments and accessories drove 85% of Q2 2026 revenue, stabilizing cash generation.
  • Penang facility in Malaysia expands manufacturing resilience for da Vinci instruments and electromechanical devices.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Hybrid Work Options

Growth & Insights and Company News

Headcount

6 month growth

0%

1 year growth

0%

2 year growth

0%
Yahoo Finance
Aug 23rd, 2026
Thermo Fisher vs Intuitive Surgical: which premium healthcare stock justifies valuation?

Thermo Fisher and Intuitive Surgical both delivered strong recent quarters, but their premium valuations rest on different foundations. Thermo Fisher's case depends on recovery in life sciences spending after the pandemic slowdown. The company's Life Sciences Solutions segment saw reported revenue climb 13% year-over-year, with organic revenue up 3%. The Analytical Instruments business returned to growth after nearly two years of weak demand, suggesting laboratory spending is normalising. Intuitive Surgical maintains its premium through business model strength. The company's non-GAAP gross profit margin reached 70.0%, whilst its non-GAAP operating margin expanded 330 basis points year-over-year to 42.1%. Recurring revenue streams constitute roughly 85% of total sales. Intuitive placed 468 da Vinci surgical units in fiscal Q2, marking 18% year-over-year growth, indicating continued hospital investment in robotic surgery platforms.

Yahoo Finance
Aug 19th, 2026
Abbott beats Q2 estimates with 13% sales growth as diagnostics surge 42%, while Intuitive Surgical posts 19% revenue rise

Abbott Laboratories reported strong fiscal Q2 2026 results, with sales rising 13% on a reported basis and 4.8% on a comparable basis, beating estimates and prompting the company to raise its annual profit forecast. The diagnostics segment was particularly strong, growing 42% to $3.09 billion, driven by its cancer diagnostics business following the Exact Sciences acquisition. Intuitive Surgical also exceeded expectations in Q2 2026, with revenue growing 19% to $2.89 billion and adjusted EPS of $2.80, beating forecasts by $0.30. The company placed 468 da Vinci units during the quarter, an 18% year-over-year increase, whilst maintaining a non-GAAP gross margin of 70.0%. The companies present contrasting investment cases: Abbott offers diversified healthcare portfolio resilience, whilst Intuitive Surgical relies on its robotic surgery ecosystem with recurring revenue comprising approximately 85% of total sales.

PR Newswire
Aug 17th, 2026
Intuitive leases 316,000-sq-ft facility in Penang to manufacture surgical instruments, create 1,200 jobs by 2032

Intuitive, the global leader in minimally invasive care and pioneer of robotic-assisted surgery, has signed a lease agreement with Penang Development Corporation for a new manufacturing facility in Malaysia. The 316,000-square-foot site in Bandar Cassia Technology Park will produce surgical instruments and electromechanical devices for Intuitive's da Vinci surgical system. The facility is expected to begin operations in 2028 and create 1,200 highly skilled jobs by 2032. The investment reflects Intuitive's commitment to Asia Pacific, where its da Vinci systems have treated more than 2.5 million patients across 13 markets over two decades. The expansion aims to support growing demand for robotic-assisted surgery across the region and strengthen Penang's position as a MedTech manufacturing hub in Southeast Asia.

Yahoo Finance
Aug 16th, 2026
Oppenheimer upgrades Intuitive Surgical to 'Outperform' with $500 price target

Oppenheimer upgraded Intuitive Surgical from "Perform" to "Outperform" with a $500 price target, implying a 24.6% upside. The analysts expect the medtech company to maintain its leading position in robotic surgery despite increasing competition. Intuitive reported strong Q2 results, with revenue rising 18.5% year-over-year to $2.89 billion, surpassing analyst expectations. Non-GAAP earnings per share climbed 27.9% to $2.80, beating the $2.50 estimate. The company placed 468 da Vinci surgical systems and 55 Ion endoluminal systems during the quarter. Combined da Vinci and Ion procedures rose approximately 16% globally. Wall Street maintains a "Strong Buy" consensus rating on the stock, with 22 of 31 analysts recommending a strong buy. The consensus price target of $480.93 represents a 19.85% upside.

Yahoo Finance
Aug 12th, 2026
Intuitive Surgical's valuation barely budges despite two years of growth forecasts

Intuitive Surgical trades at $401.23, down 32% from its 52-week high and 15% over twelve months. The stock currently trades at 37.7 times trailing adjusted earnings. Analysts forecast earnings of $12.08 per share by 2027, bringing the multiple down to 33 times — only 13% lower despite two years of growth. Consensus projects 7% annual earnings growth and 9.7% revenue growth, suggesting margin compression ahead. Management raised its 2026 gross profit margin guidance to 68-69%. However, the company plans to extend instrument use limits starting in the first half of 2027 to lower procedure costs and boost adoption. Intuitive has not finalised pricing for this programme, creating uncertainty around 2027 estimates. The company will quantify the impact on its next earnings call.